The American Society of Radiologic Technologists (ASRT) has introduced Low-Dose Computed Tomography (LDCT), an online education product designed to teach radiologic technologists LDCT screening techniques for patients with lung cancer. The module also provides guidance for radiology managers looking to provide reimbursable LDCT services to patients in the Medicare program.

The American College of Radiology (ACR) and American Association of Physicists in Medicine (AAPM) are offering a new resource document for physicians and medical physicists serving as radiation safety officers at medical facilities. The ACR-AAPM Radiation Safety Officer Resources was developed jointly by medical physicists from both associations.

A magnetic resonance imaging (MRI)-based screening program for individuals at high risk of pancreatic cancer identified pancreatic lesions in 40 percent of patients, according to a report published online by JAMA Surgery.

New evidence suggests reading to young children is in fact associated with differences in brain activity supporting early reading skills. The research was presented Saturday, April 25 at the Pediatric Academic Societies (PAS) annual meeting in San Diego.

The U.S. Food and Drug Administration (FDA) reports that it has reached an agreement with Lancaster Breast Imaging of Lancaster, Pennsylvania, in regards to a Mammography Quality Standards Act (MQSA) violation self-reported by the facility. Lancaster Breast Imaging is still performing mammography to date.

A new clinical trial is testing the feasibility and efficiency of a doctor in New York City remotely performing long-distance, tele-robotic ultrasound exams over the Internet on patients in Chicago.

Provision Center for Proton Therapy is helping pioneer a new product that will help further protect prostate cancer patients from the effects of radiation therapy. Four patients were injected with SpaceOAR hydrogel, the first product in the United States cleared just last week as a spacer to protect the rectum in men undergoing radiation therapy for prostate cancer. The SpaceOAR System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer, creating space to protect the rectum from radiation exposure. Provision is the first proton therapy center and the second radiation treatment center nationwide to adopt the product.

A UK National Cancer Research Institute trial led from The University of Manchester and the Christie NHS Foundation Trust has suggested that in patients with early stage Hodgkin lymphoma, the late effects of radiotherapy could be reduced by using a scan to determine those who actually need it.